Recent News

Upcoming Seminars and Events

View upcoming seminars and events.

Learn more
559 News Items found
MSK physician-scientist Charles Sawyers and SKI computational biologist Dana Pe’er
MSK Researchers Discover How Cancer Cells Change Identity To Escape Therapies

Researchers learn how prostate cancer cells change their type to survive treatment.
Scott Lowe
In the Lab
SKI Scientists Solve 30-Year-Old Mystery About p53 Protein — Dubbed ‘Guardian of the Genome’

Rather than promoting genetic chaos, loss of p53 leads to an orderly progression of genetic changes that no one saw coming.
SKI molecular biologist John Maciejowski
SKI Study Sheds Light on How a Natural Defense Against Viruses Can Lead to Mutations in Cancer Cells

A protein in the body that protects against viruses can also cause cancer-related mutations.
MSK pathologist Natasha Rekhtman and physician-scientist Charles Rudin
MSK Scientists Identify Rare (Rb-Proficient) Subtype of Small Cell Lung Cancer

Unlike most small cell lung cancer tumors, these retain a normal copy of a protein called RB.
Improved Scoring System for Myelodysplastic Syndromes Could Help Doctors Tailor Treatment

The revised scoring system incorporates molecular information related to 31 genes to help predict risk.
Side-by-side headshots of scientists Christopher Lima and Rhyan Puno
With Cryo-EM, SKI Scientists Determine Structure of Key Factor in RNA Quality Control

Called NEXT, the factor plays an important role in handing over RNA to the exosome for destruction.
MSK physician-scientist Yu Chen
MSK Scientists Identify New — and Very Common — Subtype of Prostate Cancer

The findings could pave the way toward more targeted treatments for the disease.
GSK dean and graduates in their caps and gowns
Event
MSK’s 2022 Convocation and Commencement Ceremony Recognizes Graduates and Award Winners

At Memorial Sloan Kettering Cancer Center’s 43rd annual event recognizing graduates and award winners, honorees were welcomed back to an in-person event.
Dan Heller
A Sensor Sniffs for Cancer, Using Artificial Intelligence

By detecting molecular signatures in the blood, the sensor may help improve cancer screenings.
SKI immunologist Ming Li
SKI Scientists Identify Potential New ‘Soldier’ for Cancer Immunotherapy

The new cells, which the scientists have dubbed killer innate-like T cells, differ in several notable ways from the conventional target of many immunotherapies.